Despite low plasma renin ACE inhibitor treatment causes recovery from acute renal failure in a patient with malignant hypertension

Nephrology Dialysis Transplantation

Volumn 13, Issue 3, 1998, Pages 769-772

  Watanabe, Takuya ^a   Yonemura, Katsuhiko ^a   Fujigaki, Yoshihide ^a   Suzuki, Takayuki ^a   Motomura, Eriko ^a   Sano, Koji ^a   Ikegaya, Naoki ^a   Yamamoto, Tatsuo ^a   Kimura, Masato ^b   Hishida, Akira ^a   Kaneko, Eizo ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Acute renal failure; Angiotensin converting enzyme inhibitors; Malignant hypertension; Renin

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RENIN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; MALIGNANT HYPERTENSION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOPSY; CREATININE; FEMALE; HUMANS; HYPERTENSION, RENAL; KIDNEY; KIDNEY FAILURE, ACUTE; MIDDLE AGED; RENIN; URINE;

EID: 6844259850     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.3.769     Document Type: Article

References (12)

1. Yoshida M, Nonoguchi H, Owada A, Ishiyama S, Maeda Y, Ando K, Iwamoto H, Shiigai T, Marumo F, Tomita K. Three cases of malignant hypertension: the roles of endothelin-1 and the renin-angiotensin-aldosterone system. Clin Nephrol 1994; 42: 295-299
2. Cottone S, Mangano MT, Fulantelli MA, Cerasola G, Salerno L, Nardi E, Lodato G, Traina C. Treatment of malignant hypertension with an angiotensin converting enzyme inhibitor. Clin Ther 1989; 11: 511-520
3. Griswold W, McNeal R, O'Connor D, Reznik V, Mendoza S. Oral converting enzyme inhibitor in malignant hypertension. Arch Dis Child 1982; 57: 235-237
4. Rasmussen S, Brahm M, Nielsen MD, Giese J, Larsen S, Brun C. Postpartum renal failure and malignant hypertension treated with captopril. Scand J Urol Nephrol 1983; 17: 209-212
5. Monnens L, Drayer J, De Jong M. Malignant hypertension in a child with hemolytic-uremic syndrome treated with captopril. Acta Paediatr Scand 1981; 70: 583-585
6. Kaplan NM. Primary aldosteronism with malignant hypertension. N Engl J Med 1963; 269: 1282-1286
7. Gravis H, Brunner HR, Laragh JH, Vaughan ED Jr, Koss M, Cote JL, Gavras I. Malignant hypertension resulting from desoxycorticosterone acetate and salt excess. Circ Res 1975; 36: 300-309
8. Case DB, Atlas SA, Sullivan PA, Laragh JH. Acute and chronic treatment of severe and malignant hypertension with the oral angiotensin-converting enzyme inhibitor captopril. Circulation 1981; 64: 765-771
9. Dzau VJ. Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 1988; 77: 14-113
10. Abernethy DR, Laurie N, Andrawis NS. Local angiotensin-converting enzyme inhibition blunts endothelin-1-induced increase in forearm vascular resistance. Clin Pharmacol Ther 1995; 58: 328-334
11. Chan DP, Clavell A, Keiser J, Barnett JC Jr. Effects of renin-angiotensin system in mediating endothelin-induced vasoconstriction: therapeutic implications. J Hypertens 1994; 12 [Suppl.]: S43-S49
12. Yoshida H, Nakamura M. Inhibition by angiotensin converting enzyme inhibitors of endothelin secretion from cultured human endothelial cells. Life Sci 1992; 50: PL195-PL200